Literature DB >> 9843215

Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16.

F M Rossi1, O M Guicherit, A Spicher, A M Kringstein, K Fatyol, B T Blakely, H M Blau.   

Abstract

Continuous regulation is required to maintain a given cell state or to allow it to change in response to the environment. Studies of the mechanisms underlying such regulation have often been hindered by the inability to control gene expression at will. Among the inducible systems available for regulating gene expression in eukaryotes, the tetracycline (tet) regulatable system has distinct advantages. It is highly specific, non-toxic and non-eukaryotic, and consequently does not have pleiotropic effects on host cell genes. Previously this system also had drawbacks, as it did not extinguish gene expression completely, precluding the study of toxic or growth-inhibitory gene products. We report here the development of a facile reversible tetracycline-inducible retroviral system (designated RetroTet-ART) in which activators and repressors together are expressed in cells. Gene expression can now be actively repressed in the absence of tet and induced in the presence of tet, as we have engineered distinct dimerization domains that allow co-expression of homodimeric tet-regulated transactivators and transrepressors in the same cells, without the formation of non-functional heterodimers. Using this system, we show that growth arrest by the cell cycle inhibitor p16 is reversible and dependent on its continuous expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843215     DOI: 10.1038/3871

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  21 in total

1.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

2.  Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.

Authors:  Jiun-Shuan Chao; Chun-Chieh Chao; Chu-Li Chang; Yi-Rong Chiu; Chiun-Jye Yuan
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

3.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.

Authors:  M M Kim; M A Rivera; I L Botchkina; R Shalaby; A D Thor; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence.

Authors:  Salvador Macip; Makoto Igarashi; Li Fang; Angus Chen; Zhen-Qiang Pan; Sam W Lee; Stuart A Aaronson
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

5.  The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.

Authors:  Vishnu Mohanan; Catherine Leimkuhler Grimes
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

6.  New use for CETSA: monitoring innate immune receptor stability via post-translational modification by OGT.

Authors:  Walter R Drake; Ching-Wen Hou; Natasha E Zachara; Catherine Leimkuhler Grimes
Journal:  J Bioenerg Biomembr       Date:  2018-04-18       Impact factor: 2.945

7.  A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain.

Authors:  K Akagi; M Kanai; H Saya; T Kozu; A Berns
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

8.  Coherent activation of a synthetic mammalian gene network.

Authors:  Diane M Longo; Alexander Hoffmann; Lev S Tsimring; Jeff Hasty
Journal:  Syst Synth Biol       Date:  2009-09-11

9.  Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice.

Authors:  F Shen; Y Fan; H Su; Y Zhu; Y Chen; W Liu; W L Young; G-Y Yang
Journal:  Gene Ther       Date:  2007-10-25       Impact factor: 5.250

10.  Heterogeneous inducible mammary-specific expression of Jab/SOCS1 in lactating transgenic mice is associated with no obvious phenotype, even at the cellular level.

Authors:  Barbara Petridou; Solange Soulier; Nathalie Besnard; Marthe Hudrisier; Catherine Hue-Beauvais; José Costa Da Silva; Jean Djiane; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2003-12       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.